116 related articles for article (PubMed ID: 3629626)
1. Deficiency of selenium intake enhances manifestation of renal toxicity of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
Toxicol Lett; 1987 Sep; 38(1-2):155-60. PubMed ID: 3629626
[TBL] [Abstract][Full Text] [Related]
2. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
[TBL] [Abstract][Full Text] [Related]
3. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
[TBL] [Abstract][Full Text] [Related]
4. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
Araya Y
Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
[TBL] [Abstract][Full Text] [Related]
5. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
[TBL] [Abstract][Full Text] [Related]
6. Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum.
Naganuma A; Satoh M; Yokoyama M; Imura N
Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):127-34. PubMed ID: 6685904
[TBL] [Abstract][Full Text] [Related]
7. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
Berry JP; Pauwells C; Tlouzeau S; Lespinats G
Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
Ren Fail; 1995 Sep; 17(5):539-50. PubMed ID: 8570866
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
Shimada H; Takahashi K; Funakoshi T; Kojima S
Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
[TBL] [Abstract][Full Text] [Related]
10. Protective role of metallothionein in renal toxicity of cisplatinum.
Satoh M; Aoki Y; Tohyama C
Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
Jones MM; Basinger MA; Mitchell WM; Bradley CA
Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
[TBL] [Abstract][Full Text] [Related]
12. Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
Imura N; Naganuma A; Satoh M; Koyama Y
Experientia Suppl; 1987; 52():655-60. PubMed ID: 2959559
[TBL] [Abstract][Full Text] [Related]
13. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
Levine BS; Henry MC; Port CD; Richter WR; Urbanek MA
J Natl Cancer Inst; 1981 Jul; 67(1):201-6. PubMed ID: 6942191
[TBL] [Abstract][Full Text] [Related]
16. Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration.
Levi FA; Hrushesky WJ; Halberg F; Langevin TR; Haus E; Kennedy BJ
Eur J Cancer Clin Oncol; 1982 May; 18(5):471-7. PubMed ID: 6889525
[TBL] [Abstract][Full Text] [Related]
17. Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice.
Satoh M; Shimada A; Zhang B; Tohyama C
Biochem Pharmacol; 2000 Dec; 60(11):1729-34. PubMed ID: 11077056
[TBL] [Abstract][Full Text] [Related]
18. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
[TBL] [Abstract][Full Text] [Related]
19. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
[TBL] [Abstract][Full Text] [Related]
20. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
Suzuki CA; Cherian MG
Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
